Suski et al. showed that the activation of the FFAR4 in apoE-/- mice by GW9508 leads to significant decrease of atherosclerosis associated with specific reduction in the number of proinflammatory M1 type macrophages in plaques, as evidenced by immunohistochemical and molecular methods [43]. This evidence concerns the gene FFAR4 and atherosclerosis.